// COMPANY
Specific Biologics
SECTOR BIOTECHMENTIONS 2LAST SEEN NOVEMBER 3, 2026
Discussed in
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
funding·StrictlyVC·NOVEMBER 4, 2026
“Specific Biologics develops gene-editing therapies that remove disease-causing repetitive DNA sequences linked to serious genetic disorders.”
Source→02
funding·PitchBook News·NOVEMBER 3, 2026
“Specific Biologics... which develops gene-editing therapies for genetic diseases, raised a $35 million Series A led by Hatteras Venture Partners.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.